Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 7,630.00
-550.00 (-6.72%)
At close: Oct 8, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 117.25 billion as of October 8, 2026. It is the 25,880th most valuable company in the world and the 1,170th biggest in South Korea. Its market cap has decreased by 44.26% in one year.
Market Cap
117.25B
Enterprise Value
95.23B
Revenue
3.17B
Global Rank
Country Rank
#1,170 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 5, 2023, Y-Biologics's market cap has decreased from 177.50B to 117.25B, a decrease of -33.94%. That is a compound annual growth rate of -13.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 117.25B | -66.27% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 182.68B |
| Kanaph Therapeutics | 174.77B |
| Bio Solution | 174.44B |
| ISU Abxis | 164.73B |
| TiumBio | 141.93B |
| Ensol Biosciences | 131.40B |
| ViGenCell | 120.95B |
| Prestige Biologics | 109.32B |